Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
暂无分享，去创建一个
A. Khorana | A. Cohen | G. Brobert | A. Ekbom | C. Coleman | Agnes Y. Y. Lee | M. Carrier | C. Becattini | Marcela Rivera | B. Schaefer | Christopher W. Brescia | Khaled Abdelgawwad | George Psaroudakis | K. S. Caroti